Therapeutic bacteria programmed to eliminate tumours
The Programme d’intégration de la génomique – volet santé humaine fostered a partnership between Professor Lee-Hwa Tai, Université de Sherbrooke, and TATUM Bioscience, a pioneer in the area of “synthetic live-biotherapeutics,” aiming to develop therapeutic bacteria capable of targeting and eliminating tumours. This radically innovative therapeutic approach will help doctors better treat resistant cancers and contribute to the improvement of Canadians’ health in the long term. Lead Genome Centre: Génome Québec [...]
Recherche québécoise sur la pharmacogénomique cardiovasculaire
Building towards the clinical application of pharmacogenomics in the treatment of cardiovascular diseases. This project, led by Drs Jean-Claude Tardif and Michael Phillips from the Montreal Heart Institute, in partnership with VIA Pharmaceuticals, aims at continuing the development of the necessary framework to support pharmacogenomics clinical trials in cardiovascular diseases in Québec andCanada. Acute Coronary Syndrome (ACS) is a leading cause of morbidity and mortality in western countries. To address this [...]
